The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma.
The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma.
复制标题
视网膜肾素-血管紧张素-醛固酮系统:对青光眼的影响。
DOI:
10.3390/antiox11040610
复制
发表时间:
2022-03-22
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Aldosterone is one of the main effectors of the renin-angiotensin-aldosterone system (RAAS) along with having roles in hypertension, and cardiovascular and renal diseases. Recent evidence has also shown the presence of an active local RAAS within the human eye. It has been shown that at 12 h after a retinal ischemia-reperfusion injury, there is an upregulation of the protein levels of angiotensin II type 1 receptor (AT1-R) in the retina. Furthermore, at 12 h after reperfusion, there is an increase in reactive oxygen species (ROS) production in the retina that is mediated via an NADPH oxidase pathway. This ischemia-reperfusion injury-induced increase of retinal ROS levels and NADPH oxidase expression can be prevented by the administration of an AT1-R antagonist. This suggests that one of the main retinal ischemic injury pathways is via the local RAAS. It has also been reported that progressive retinal ganglion cell loss and glaucomatous optic nerve degeneration without elevated intraocular pressure occur after administration of local or systemic aldosterone. Elucidation of glaucoma pathogenesis, especially normal-tension glaucoma (NTG) subtype by our current animal model can be used for identifying potential therapeutic targets. Based on these results, we are further evaluating NTG prevalence among primary aldosteronism patients.
登录
查看更多内容
影响因子:
8.3
作者:
Fujita, M;Minamino, T;Kitakaze, M
通讯作者:
Kitakaze, M
影响因子:
8.3
作者:
Deliyanti, Devy;Miller, Antonia G.;Wilkinson-Berka, Jennifer L.
通讯作者:
Wilkinson-Berka, Jennifer L.
影响因子:
4.8
作者:
DEINUM, J;DERKX, FHM;SCHALEKAMP, MADH
通讯作者:
SCHALEKAMP, MADH
影响因子:
5.8
作者:
DANSER, AHJ;VANDENDORPEL, MA;SCHALEKAMP, MADH
通讯作者:
SCHALEKAMP, MADH
影响因子:
4.2
作者:
Drance, S;Anderson, DR;Schulzer, M
通讯作者:
Schulzer, M